Safety, immunogenicity, and dose ranging of a bivalent respiratory syncytial virus and human metapneumovirus glycoprotein F-molecular clamp vaccine candidate in older adults: 1-month interim analysis of an ongoing randomised, observer-blind, placebo- and active-controlled, phase 1 trial.

Della Cioppa G, Sahai N, Dodeur V, Dutton JL, Moller C, O'Donnell JS, Young A, Gillard M, Harrison M, Wolf R, Kulenovic S, Chappell KJ, Magdalena J, Hanon E

Open source

DOI: 10.1016/j.vaccine.2026.128772
Published: 2026 Jul 11
Container: Vaccine
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.vaccine.2026.128772,
  title = {Safety, immunogenicity, and dose ranging of a bivalent respiratory syncytial virus and human metapneumovirus glycoprotein F-molecular clamp vaccine candidate in older adults: 1-month interim analysis of an ongoing randomised, observer-blind, placebo- and active-controlled, phase 1 trial.},
  author = {Della Cioppa G and Sahai N and Dodeur V and Dutton JL and Moller C and O'Donnell JS and Young A and Gillard M and Harrison M and Wolf R and Kulenovic S and Chappell KJ and Magdalena J and Hanon E},
  year = {2026},
  journal = {Vaccine},
  doi = {10.1016/j.vaccine.2026.128772},
  url = {https://doi.org/10.1016/j.vaccine.2026.128772}
}

RIS

TY  - JOUR
TI  - Safety, immunogenicity, and dose ranging of a bivalent respiratory syncytial virus and human metapneumovirus glycoprotein F-molecular clamp vaccine candidate in older adults: 1-month interim analysis of an ongoing randomised, observer-blind, placebo- and active-controlled, phase 1 trial.
AU  - Della Cioppa G
AU  - Sahai N
AU  - Dodeur V
AU  - Dutton JL
AU  - Moller C
AU  - O'Donnell JS
AU  - Young A
AU  - Gillard M
AU  - Harrison M
AU  - Wolf R
AU  - Kulenovic S
AU  - Chappell KJ
AU  - Magdalena J
AU  - Hanon E
PY  - 2026
JO  - Vaccine
DO  - 10.1016/j.vaccine.2026.128772
UR  - https://doi.org/10.1016/j.vaccine.2026.128772
ER  -

APA

G, D. C., N, S., V, D., JL, D., C, M., JS, O., A, Y., M, G., M, H., R, W., S, K., KJ, C., J, M., & E, H. (2026). Safety, immunogenicity, and dose ranging of a bivalent respiratory syncytial virus and human metapneumovirus glycoprotein F-molecular clamp vaccine candidate in older adults: 1-month interim analysis of an ongoing randomised, observer-blind, placebo- and active-controlled, phase 1 trial.. Vaccine. https://doi.org/10.1016/j.vaccine.2026.128772

Source records

pubmed · retrieved 2026-09-26T15:20:46.688Z
europe-pmc · retrieved 2026-09-26T15:20:46.679Z